While supplies last! Free 2022 Essentials of Interventional Radiology Coding book with every ICD10monitor webcast order. No code required. Order now >

“The whole issue of end-to-end testing is a relatively large, time-consuming, and expensive investment for all parties,” stated Dennis Winkler, technical program director of program management at Michigan Blue Cross/Blue Shield of Michigan. “Historically, it usually ends up being used by larger providers, institutions and payers.”

John Wollman, executive vice president of Highpoint Solutions, adds that end-to-end testing also is not “immediately implementable.” In fact, at this point, many providers, clearinghouses, and payers don’t have the systems in place to support end-to-end testing.

Facebook
Twitter
LinkedIn
Email
Print

Janis Oppelt

Janis Oppelt was the former editorial director for MedLearn Publishing.

You May Also Like

Medlearn Media NPOS Non-patient outcome spending

The PHE Update

The renewal of the PHE indicates that a public health emergency (PHE) exists. As expected, the COVID-19 PHE (Public Health Emergency) was extended for the

Read More

Leave a Reply

Your Name(Required)
Your Email(Required)